1h-Indole-3-acetic acid,1-(4-chlorobenzoyl)-4-methoxy-2-methyl- | 5159-08-0

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吲哚及其衍生物
• 英文名称: 1h-Indole-3-acetic acid,1-(4-chlorobenzoyl)-4-methoxy-2-methyl-
• 英文别名: 2-[1-(4-chlorobenzoyl)-4-methoxy-2-methylindol-3-yl]acetic acid
• CAS: 5159-08-0
• 化学式: C₁₉H₁₆ClNO₄
• 分子量: 357.8
• InChiKey: QYAYNUDGPJYYSH-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.3
• 重原子数：
  25
• 可旋转键数：
  4
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.16
• 拓扑面积：
  68.5
• 氢给体数：
  1
• 氢受体数：
  4

文献信息

• Improved anti-inflammatory combinations having reduced ulcerogenicity
  申请人：Merck & Co., Inc.

  公开号：EP0017169A1

  公开（公告）日：1980-10-15

  A novel drug combination for more effective treatment of pain, fever, and inflammation with reduced ulcerogenicity comprising either 1-(p-chlorobenzoyl)-5-methoxy-2-methylindo|e-3-acetic acid (indomethacin), and (b) a member selected from phenyl benzoic acid compounds, especially 2-hydroxy-5-(2',4'-difluorophenyl)benzoic acid (diflunisal), wherein the molar ratio of (b) to (a) is from 0.5 to 1.0 to 15.0 to 1.0; or a member selected from (b) and one or more members selected from ibuprofen, ketoprofen, naproxen, diclofenac sodium, tolmetin, flurbiprofen, indoprofen, benozaprofen, piroxicam.

  一种用于更有效地治疗疼痛、发热和炎症并降低溃疡发生率的新型药物组合，包括 1-(对氯苯甲酰基)-5-甲氧基-2-甲基吲哚|e-3-乙酸(吲哚美辛)，和(b)选自苯基苯甲酸化合物，特别是 2-羟基-5-(2',4'-二氟苯基)苯甲酸(二氟尼柳)的成员，其中(b)与(a)的摩尔比为 0.5至1.0至15.0至1.0；或选自(b)和一种或多种选自布洛芬、酮洛芬、萘普生、双氯芬酸钠、托美汀、氟比洛芬、吲哚洛芬、苯唑洛芬、吡罗昔康的成员。
• Emollient-containing skin conditioning compositions
  申请人：THE PROCTER & GAMBLE COMPANY

  公开号：EP0103910A1

  公开（公告）日：1984-03-28

  Skin conditioning compositions are described which comprise an emulsion of petrolatum; water; an unsaturated monoglyceride emulsifier; and a skin conditioning agent, preferably glycerine. As a result of the novel cubic, viscous isotropic dispersed phase of these water-in-oil emulsions, they possess the ability to incorporate and deliver relatively high levels of glycerine while retaining high cosmetic acceptance.

  所述的皮肤调理组合物由凡士林油乳液、水、不饱和单甘油酯乳化剂和皮肤调理剂（最好是甘油）组成。由于这些油包水型乳液具有新颖的立方体、粘性各向同性分散相，因此能够掺入并提供相对较高的甘油含量，同时保持较高的化妆品接受度。
• Esters and amides of substituted pyrrole acetic acids
  申请人：FGN, INC.

  公开号：EP0485157A2

  公开（公告）日：1992-05-13

  Esters and amides of substituted pyrrole acetic acids of the formula : wherein n is 0 or 1, and X represents a condensed phenyl ring ; one of R1 and R2 is independently selected from hydrogen, halogen, lower alkyl ; and the other of R1 and R2 is independently selected from substituted or unsubstituted phenyl, benzyl, thienyl, napthyl, pyridyl, furyl, biphenyl, benzoyl, cinnamoyl, thienylcarbonyl, napthylcarbonyl, pyridylcarbonyl, furylcarbonyl or biphenylcarbonyl wherein said substituents are selected from amino, halogen, lower alkyl, lower alkylthio, lower alkoxy or lower haloalkyl ; m is an integer from 1 to 3 ; R3 is selected from hydrogen and lower alkyl, or one or more of hydrogen and lower alkyl when m is greater than 1 ; R4 is one or more of hydrogen, lower alkyl, alkoxy, haloalkyl, alkylthio, and halogen ; p is an integer of at least 2 ; Q is the deprotonated residue of a polymer or macromolecular structure having at least two primary and/or secondary amines and/or hydroxy groups ; and when n is 0, R5 is selected from hydrogen, halogen, lower alkyl, alkoxy, alkylthio, and halogen are useful in the treatment of colonic polyps.

  式中取代的吡咯乙酸的酯和酰胺： 其中 n 为 0 或 1，X 代表缩合苯基环； R1 和 R2 中的一个独立选自氢、卤素、低级烷基；R1 和 R2 中的另一个独立选自取代或未取代的苯基、苄基、噻吩基、萘基、吡啶基、呋喃基、联苯基、苯甲酰基、肉桂酰基、噻吩基羰基、萘基羰基、吡啶基羰基、呋喃基羰基或联苯基羰基，其中所述取代基选自氨基、卤素、低级烷基、低级烷硫基、低级烷氧基或低级卤代烷基； m 是 1 至 3 的整数； R3 选自氢和低级烷基，或当 m 大于 1 时，选自氢和低级烷基中的一个或多个； R4 是氢、低级烷基、烷氧基、卤代烷基、烷硫基和卤素中的一种或多种； p 是至少 2 的整数； Q 是聚合物或大分子结构的去质子化残基，至少有两个伯胺和/或仲胺和/或羟基；以及 当 n 为 0 时，R5 选自氢、卤素、低级烷基、烷氧基、烷硫基和卤素。
• US5721347A
  申请人：——

  公开号：US5721347A

  公开（公告）日：1998-02-24